/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Geron Corporation

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.25 0.0325(3.25%) GERN at 04 Dec 2025 04:33 PM Biotechnology
Lowest Today 1.23
Highest Today 1.28
Today’s Open 1.23
Prev. Close 1.23
52 Week High 4.09
52 Week Low 1.04
Day’s Range: Low 1.23 High 1.28
52-Week Range: Low 1.04 High 4.09
1 day return -
1 Week return +8.51
1 month return +11.35
3 month return -7.27
6 month return -16.93
1 year return -68.04
3 year return -44.56
5 year return -29.36
10 year return -

Institutional Holdings

RA Capital Management, LLC 9.46

BlackRock Inc 7.84

Deep Track Capital, LP 6.74

Vanguard Group Inc 5.58

Vivo Capital, LLC 4.27

Vestal Point Capital LP 3.73

State Street Corp 3.70

Vanguard Total Stock Mkt Idx Inv 3.01

Soleus Capital Management, L.P. 2.53

iShares Russell 2000 ETF 2.27

ClearBridge Advisors, LLC 2.25

Geode Capital Management, LLC 2.22

BioPharma Credit Ord 2.21

Morgan Stanley - Brokerage Accounts 2.08

Citadel Advisors Llc 1.89

UBS Group AG 1.84

SPDR® S&P Biotech ETF 1.58

Goldman Sachs Group Inc 1.54

Point72 Asset Management, L.P. 1.51

Fidelity Select Biotechnology 1.42

Vanguard Explorer Inv 1.40

Woodline Partners LP 1.25

Eversept Partners, LLC 1.15

Segall Bryant & Hamill 1.13

Aberdeen Group PLC 1.09

StemPoint Capital LP 1.04

Fidelity Small Cap Index 0.96

Vanguard Institutional Extnd Mkt Idx Tr 0.96

iShares Russell 2000 Growth ETF 0.83

ClearBridge Small Cap Growth 0.59

ClearBridge Small Cap Growth A 0.59

abrdn Healthcare Investors 0.57

iShares Biotechnology ETF 0.57

Xtrackers MSCI World Swap ETF 1C 0.52

Fidelity Extended Market Index 0.47

Vanguard Russell 2000 ETF 0.45

Schwab US Small-Cap ETF™ 0.41

EdRF Healthcare A EUR 0.37

State St Russell Sm Cap® Indx SL Cl I 0.32

abrdn Life Sciences Investors 0.30

Market Status

Strong Buy: 4

Buy: 2

Hold: 3

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 785.18 M

PB Ratio 3.08

PE Ratio 0.0

Enterprise Value 507.41 M

Total Assets 593.78 M

Volume 7663733

Company Financials

Annual Revenue FY23:317000 0.3M, FY22:596000 0.6M, FY21:1393000 1.4M, FY20:253000 0.3M, FY19:460000 0.5M

Annual Profit FY23:null 0.0M, FY22:596000 0.6M, FY21:1393000 1.4M, FY20:253000 0.3M, FY19:460000 0.5M

Annual Net worth FY23:-174789000 -174.8M, FY22:-141033000 -141.0M, FY21:-120952000 -121.0M, FY20:-75610000 -75.6M, FY19:-63551000 -63.6M

Quarterly Revenue Q3/2025:47227000 47.2M, Q2/2025:49036000 49.0M, Q1/2025:39603000 39.6M, Q3/2024:28271000 28.3M, Q2/2024:882000 0.9M

Quarterly Profit Q3/2025:25114000 25.1M, Q2/2025:47846000 47.8M, Q1/2025:38397000 38.4M, Q3/2024:28209000 28.2M, Q2/2024:436000 0.4M

Quarterly Net worth Q3/2025:-18428000 -18.4M, Q2/2025:-16375000 -16.4M, Q1/2025:-19835000 -19.8M, Q3/2024:-26447000 -26.4M, Q2/2024:-67383000 -67.4M

Fund house & investment objective

Company Information Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Organisation Biotechnology

Employees 229

Industry Biotechnology

CEO Mr. Harout Semerjian

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow